美股新聞 標題聯播 · 近 24 小時 251 則 · 32 個來源 · 最新 9/20 02:40
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · LLY近 30 天 29 則 · 第 1 / 1 頁
- 如何為下一波 AI 主導的科學突破做好布局How to position for the next wave of AI-led scientific breakthroughs
- 一家製藥商正從減重藥物的副作用中獲益A drugmaker is gaining from the side effects of weight-loss drugs
- Why Twist Bioscience Stock Skyrocketed This Week
- 能源類股怎麼看？What About the Energy Sector?
- What Would It Take For Eli Lilly Stock To Keep Climbing?
- Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation?
- Is Johnson & Johnson Stock Expensive, Or Is STELARA Hiding The Real Price?
- 類股更新：醫療保健股午盤後走軟Sector Update: Healthcare Stocks Softer Late Afternoon
- Merck Stock Nearly Doubled Without A Change In Its Revenue Growth
- 美國 FDA 核准 Inluriyo（imlunestrant）合併 Verzenio（abemaciclib）用於治療 ER+、HER2-、ESR1 突變的晚期或轉移性乳癌成人患者U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
- 諾和諾德執行長稱該藥廠需要「重新思考」其減重策略Novo CEO Says Drugmaker Needs to “Rethink” its Obesity Strategy
- 4 Biotech Stocks to Watch as Potential Takeover Targets
- Better Buy for Cautious Investors: Eli Lilly vs Costco
- 阿斯特捷利康的廣泛產品線能否抵銷近期挫敗？Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
- 嬌生三個月漲 18%：該買進、賣出還是續抱？J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
- 禮來最新多頭派：近 300% 漲勢只是開始Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning
- AlzeCure Pharma 在與 Eli Lilly 及 QuantumCell 達成協議後發布更新公司簡報AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements
- Eli Lilly (LLY) 從其新的基因醫學合作中獲得什麼？What Does Eli Lilly (LLY) Gain From Its New Genetic Medicine Partnership?
- 1 檔值得關注的穩健股票和 2 檔我們有疑問的股票1 Safe-and-Steady Stock Worth Your Attention and 2 We Question
- 一款失敗的降膽固醇藥也提高了安進 (AMGN) 與禮來 (LLY) 的風險A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
- Can Volume Keep Covering Eli Lilly's Price Cuts?
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- 3 Healthcare Stocks for 3 Stages of Life
- Thatch Raises $108M at $1B Valuation as Employers Shift Away From Traditional Health Plans
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
- Is This LLY Stock Dip Big Enough To Be Worth Buying?
- Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets
- Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
- Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。